Post by
NohupMy on Nov 03, 2015 10:19pm
2nd Phase 3 trial possibly needed
The is the likelihood of the FDA recommending the 2nd Phase 3. Most clinical trials require two Phase 3 trials to be run, typically sequentially and sometimes concurrently. Some trials have a single Phase 3 declared at the start as a pivotal Phase 3. In this case the 1st Phase 3 was not initiated as a pivotal trial.
The first Phase 3 enrolled 129 patients and took 4&1/2 years to complete.
There is a reason the stock price is cheap.
Comment by
1wascallywabbit on Nov 03, 2015 10:39pm
So you don't have any shares of course ...and joined Stockhouse today just to make a post on this board for which you have no connection. Please explain your motive.
Comment by
ragingbull1327 on Nov 04, 2015 7:53am
If that's what they recommend, then they should all be removed. There is NOTHING better. NOTHING. And they've waited an eternity for someone else to try and make something better. Nope. Why doesnt the fda just cure it all. Come up with their own treatments. They seem to be so powerful, they should be able to do it all. :)
Comment by
ragingbull1327 on Nov 04, 2015 8:28am
I said yesterday that the next stop is 0.96. Wrong. 0.87 is the new 0.96. Once it clears .87, it's going to take even more foolish trading to keep it from going to $1.50+
Comment by
ragingbull1327 on Nov 04, 2015 8:53am
In their presentations to big money, I would create a slide and keep referencing back to it. Call it "the alternative to MCNA". The slide will be blank. Completely. Because there is NOTHING. This is a tough nut to crack, or what?
Comment by
ragingbull1327 on Nov 04, 2015 8:57am
Actually, I forgot about the treatment that mocks them. ThereAllLazy